AIxCrypto Holdings (AIXC)
NASDAQ:AIXC
Want to see AIXC full AI Analyst Report?
AIXC Stock Chart & Stats
$2.65
--
Market closed
$2.65
--
Day’s Range― - ―
52-Week Range$0.92 - $8.81
Previous CloseN/A
VolumeN/A
Average Volume (3M)2.38M
Market Cap
$26.10M
Enterprise Value$455.77K
Total Cash (Recent Filing)$6.20M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.90
Next Earnings
Aug 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.23
Shares Outstanding20,234,993
10 Day Avg. Volume295,576
30 Day Avg. Volume2,383,814
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.20
Price to Sales (P/S)0.00
P/FCF Ratio-0.24
Enterprise Value/Market Cap0.02
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-4.32
Enterprise Value/Ebitda-0.02
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Financial LeverageMinimal debt and a materially larger equity base improve financial flexibility and reduce near-term solvency risk. This capital structure supports continued R&D and platform build-out without interest burden, giving management time to execute the strategic pivot before relying on costly external debt.
Strategic Pivot To AI, Blockchain, RWAThe shift from biopharma to AI/blockchain/RWA targets structural markets with larger addressable market and multiple monetization paths. Building AI Agent, tokenization and enterprise data rails and early partnerships creates durable platform optionality if product-market fit and enterprise adoption follow.
Stronger Leadership And CapitalizationA fresh leadership team, Nasdaq governance and a sizable PIPE provide institutional credibility, capital runway and managerial capacity to scale platform work. Formalized executive incentives align management to long-term milestones, increasing the odds of disciplined execution and partner development.
Bears Say
No Revenue / Widening LossesPersistent pre-revenue status and materially larger losses indicate the company has not proven a revenue model. Continued negative profitability erodes equity returns and elevates dependency on external capital; absent clear ramp in commercial contracts, structural viability remains unproven.
Sustained Cash BurnConsistent negative operating and free cash flow, and recent large cash outflows, mean the business consumes capital faster than it generates it. This creates structural reliance on financings or asset monetization, increasing dilution risk and pressuring long-term investment plans if revenues lag.
Concentrated FFAI ExposureDeepening exposure to a single issuer and complex instruments creates concentration and counterparty risk. Tying part of the business model to FFAI tokenization and outcomes magnifies execution and liquidity risk, potentially impairing asset realizations and strategic flexibility over months.
AIxCrypto Holdings News
AIXC FAQ
What was AIxCrypto Holdings’s price range in the past 12 months?
AIxCrypto Holdings lowest stock price was $0.92 and its highest was $8.81 in the past 12 months.
What is AIxCrypto Holdings’s market cap?
AIxCrypto Holdings’s market cap is $26.10M.
When is AIxCrypto Holdings’s upcoming earnings report date?
AIxCrypto Holdings’s upcoming earnings report date is Aug 18, 2026 which is in 83 days.
How were AIxCrypto Holdings’s earnings last quarter?
AIxCrypto Holdings released its earnings results on May 11, 2026. The company reported -$0.789 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.789.
Is AIxCrypto Holdings overvalued?
According to Wall Street analysts AIxCrypto Holdings’s price is currently Overvalued.
Does AIxCrypto Holdings pay dividends?
AIxCrypto Holdings does not currently pay dividends.
What is AIxCrypto Holdings’s EPS estimate?
AIxCrypto Holdings’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does AIxCrypto Holdings have?
AIxCrypto Holdings has 20,234,993 shares outstanding.
What happened to AIxCrypto Holdings’s price movement after its last earnings report?
AIxCrypto Holdings reported an EPS of -$0.789 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -13%.
Which hedge fund is a major shareholder of AIxCrypto Holdings?
Currently, no hedge funds are holding shares in AIXC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
AIxCrypto Holdings
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
Ownership Overview
―
Insiders
0.06% Mutual Funds
<0.01% Other Institutional Investors
99.87% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---